EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Selenium in Prostate Cancer: Prevention, Progression, and Treatment

Jinjiang Jiang, Bo Chen, Bo Tang, Qiang Wei iD

Pharmaceuticals · 05.09.2023 · 16 (9) · 1250

DOI: 10.3390/ph16091250 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 05.09.2023. Verfasst von Jinjiang Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu 610041, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selenium, a trace mineral with various biological functions, has become a focal point in prostate cancer research. This review aims to present a comprehensive overview of selenium’s involvement in prostate cancer, covering its impact on prevention, development, treatment, and underlying mechanisms. Observational studies have revealed a link between selenium levels and selenoproteins with prostate cancer progression. However, randomized controlled studies have shown that selenium supplementation does not prevent prostate cancer (HR: 0.95; 95% CI 0.80–1.13). This discrepancy might be attributed to selenoprotein single nucleotide polymorphisms. In the context of combinatorial therapy, selenium has demonstrated promising synergistic potential in the treatment of prostate cancer. Emerging evidence highlights the significant role of selenium and selenoproteins in prostate cancer, encompassing AR signaling, antioxidative properties, cell death, cell cycle regulation, angiogenesis, epigenetic regulation, immunoregulation, epithelial–mesenchymal transformation, and redox signal. In conclusion, selenium’s diverse properties make it a promising trace mineral in prostate cancer prevention, development, and treatment and as a platform for exploring novel agents.

Schlagwörter

Stichwörter der Autor:innen

chemopreventionprogressionprostate cancerseleniumselenoproteintherapy

Autor:innen und Institutionen

  • Department of Urology, West China Hospital of Sichuan University, No. 37, Guoxue Lane, Chengdu 610041, China.
  • Institute of Urology, West China Hospital of Sichuan University, Chengdu 610041, China.

ORCID-Profile: Qiang Wei

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program

Zitieren

APA

Jiang, J., Chen, B., Tang, B., & Wei, Q. (2023). Selenium in Prostate Cancer: Prevention, Progression, and Treatment. Pharmaceuticals, 16(9), 1250. https://doi.org/10.3390/ph16091250

Vancouver

Jiang J, Chen B, Tang B, Wei Q. Selenium in Prostate Cancer: Prevention, Progression, and Treatment. Pharmaceuticals. 2023;16(9):1250. doi:10.3390/ph16091250

BibTeX
@article{Jiang2023,
  author = {Jiang, Jinjiang and Chen, Bo and Tang, Bo and Wei, Qiang},
  title = {Selenium in Prostate Cancer: Prevention, Progression, and Treatment},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {9},
  pages = {1250},
  doi = {10.3390/ph16091250}
}
Kostenlos starten →